RGAGX | TWGIX | RGAGX / TWGIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 30.122 | 25.643 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 16.2B | 1,889% |
Annual Yield % from dividends | 0.75 | 0.00 | - |
Returns for 1 year | 31.73 | 27.03 | 117% |
Returns for 3 years | -0.67 | 3.70 | -18% |
Returns for 5 years | 58.51 | 68.15 | 86% |
Returns for 10 years | 77.81 | 79.41 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 71.20 | 0.21 | +0.29% |
Invesco Biotechnology & Genome ETF | |||
UMAR | 35.59 | N/A | N/A |
Innovator U.S. Equity Ultra BffrETF™-Mar | |||
IMCB | 79.82 | -0.09 | -0.11% |
iShares Morningstar Mid-Cap ETF | |||
SCHA | 27.35 | -0.24 | -0.87% |
Schwab US Small-Cap ETF™ | |||
BBP | 65.21 | -2.49 | -3.68% |
Virtus LifeSci Biotech Products ETF |